News Detail
New Delhi, 11 Dec 2024: The National Pharmaceutical Pricing Authority (NPPA) mandates for hospitals performing angioplasty to itemize billing costs for non-stent components alongside coronary stent details, Minister of State for Chemicals and Fertilizers, Anupriya Patel, recently......
View Details
Source : Medical Dialogues
national pharmaceutical pricing authority
nppa
coronary stents
angioplasty
billing transparency
non-stent components
price caps
cardiac catheters
balloon catheters
guide wire
dpco 2013
maximum retail price
mrp
healthcare institutions
itemized billing
hospital compliance
price inflation
accessibility
affordability
s v venkatesan
anupriya patel
parliamentary session
cardiac stent availability
price regulation
medical devices
non-scheduled devices
2023 study
lok sabha
Related News
- Combining BCL-2 and BTK inhibitors shows promise in chronic lymphocytic leukemia (CLL) (11-12-2024)
- Punjab cop arrests man for narcotic drugs case, gets fined by court (11-12-2024)
- Board of Alkem Laboratories approves transfer of its trade generics biz to Alkem Wellness (11-12-2024)
- Instructions for inspection of food manufacturing units (11-12-2024)
- PCB levies 31L penalty on pharma manufacturing unit over violations (11-12-2024)
- FDI equity inflow into pharma sector grows to $520 million in H1FY25 (11-12-2024)
- Govt Expands Jan Aushadhi Kendras in Rural Areas Through PACS Collaboration (11-12-2024)
- Unexplained sudden deaths among youth not linked to Covid vaccines: JP Nadda in RS (11-12-2024)
- Fake food supplement factory busted, 3 arrested, goods worth Rs 50 lakh seized (11-12-2024)
- Fake medicines factory busted in Modinagar, UP (10-12-2024)